Anemia

Investigators ID Factors Affecting Predialysis Hemoglobin Control

Publish Date March 5, 2021

Study findings reinforce the value of treating anemia during the transition to dialysis and illustrate the problem of ESA hyporesponsiveness.

World Kidney Day 2021: Living Well With Kidney Disease

Publish Date February 17, 2021

The World Kidney Day Steering Committee has declared 2021 the year of “Living Well with Kidney Disease”.

Canagliflozin May Reduce Anemia Risk in Diabetic CKD

Publish Date February 1, 2021

In the CREDENCE trial, patients receiving canagliflozin had reduced risks of initiating iron therapy and erythropoiesis-stimulating agents compared with patients receiving placebo.

Iron Replacement Therapy Triferic AVNU Now Available

Publish Date January 29, 2021

Triferic is an iron maintenance therapy that delivers between 5 to 7mg of iron with every hemodialysis treatment and maintains hemoglobin without increasing ferritin.

Early Transfusion May Not Worsen Kidney Graft Outcomes in Selected Cases

Publish Date January 26, 2021

Perioperative transfusion of blood products was not associated with worse clinical outcomes or allosensitization in a study of selected kidney transplant recipients.

FDA Requests Clarification of Data to Complete Roxadustat Review

Publish Date January 8, 2021

The Agency announced that additional clarification of clinical data was needed prior to completing the review.

Anti-Inflammatory Drug May Improve ESA Hyporesponsiveness in HD

Publish Date January 7, 2021

In a short-term trial involving hemodialysis patients, ziltivekimab significantly improved erythropoietin resistance index.

IV Iron Products: Adverse Events, Associated Costs Compared

Publish Date January 6, 2021

The comparative study aimed to analyze AEs as well as estimate the associated medical costs for 4 IV iron preparations.

Molidustat Noninferior to Darbepoetin in Hemodialysis

Publish Date December 9, 2020

The new evidence further supports development of the investigational HIF-PHI, which recently also demonstrated noninferiority to darbepoetin in patients with chronic kidney disease not receiving dialysis.

Iron Deficiency Is Associated With Worse Quality of Life in CKD

Publish Date December 9, 2020

Low transferrin saturation was associated with worse physical quality of life in patients with CKD, even in those free of anemia.